Cancer and aids: New trends in drug design and chemotherapy

Current Computer-Aided Drug Design

Volumn 2, Issue 3, 2006, Pages 307-324

  Taft, Carlton Anthony ^a   Tomich de Paula da Silva, Carlos Henrique ^b  

^a CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti VEGF antibody; HIV 1; Molecular modeling (MM); Non nucleoside reverse transcriptase inhibitors (N; chemokine co receptors

Indexed keywords

DIAGNOSIS; DISEASES;

ANTI-VEGF ANTIBODY; CHEMOKINE CO-RECEPTOR; CHEMOKINES; CORECEPTORS; DRUG DESIGN; DRUG DISCOVERY; HIV-1; MOLECULAR MODELING; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (N;; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;

CHEMOTHERAPY;

ABACAVIR; ALKYLATING AGENT; AMINOPTERIN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DIDANOSINE; DNA TOPOISOMERASE INHIBITOR; ENFUVIRTIDE; FOLINIC ACID; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDINAVIR; LOPINAVIR; MERCAPTOPURINE; METHOTREXATE; PACLITAXEL; PREDNISONE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; UNINDEXED DRUG; VINCA ALKALOID; VINCRISTINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; ARTIFICIAL NEURAL NETWORK; BIOLOGICAL ACTIVITY; BONE MARROW SUPPRESSION; CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER AIDED DESIGN; COMPUTER MODEL; DATA BASE; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; EMPIRICAL RESEARCH; ERADICATION THERAPY; GENETIC ALGORITHM; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; INTERMETHOD COMPARISON; LEUKEMIA; LIGAND BINDING; LYMPHATIC LEUKEMIA; LYMPHOMA; MONOTHERAPY; MORBIDITY; MORTALITY; NEPHROTOXICITY; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PHENOTYPE; PHYSICAL CHEMISTRY; PREDICTION; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; QUANTUM CHEMISTRY; REVIEW; SEXUAL INTERCOURSE; SOLID TUMOR; TESTIS CANCER; THROMBOCYTE TRANSFUSION; TOXICITY TESTING; TREATMENT OUTCOME; TREND STUDY; VIRUS INHIBITION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; X RAY CRYSTALLOGRAPHY;

EID: 33748674624     PISSN: 15734099     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340906778226382     Document Type: Review

References (131)

1. Barre-Simoussi, F. Science, 1983, 220, 868.
2. Ezzell, C. Nature, 1987, 329, 751.
3. Silberner, J. Sci. News, 1985, 127, 148.
4. Furman, P.A.; Barry, D.W. Am. J. Med, 1988, 85, 176
5. Richman, D.D. Nature, 2001, 410, 995.
6. Gershon, D. Nature, 1991, 353, 589.
7. Pomerantz, R.J. JAMA, 1991, 282, 1177.
8. Pomerantz, R.J. AIDS, 2001, 15, 1201
9. De Clercq, E. Med. Res. Rev., 2002, 22, 531.
10. Gaddis, N.C.; Chertova, E.; Sheehy, A.M.; Henderson; L.E.; Malim, M.H. J. Virol., 2003, 77, 5180.
11. Sheehy, A.M.; Gaddis, N.C.; Choi, J.D.; Malim, M.H. Nature, 2002, 418, 646.
12. Turner, B.G.; Summers, M.F. J. Mol. Biol., 1999, 285, 1.
13. Ho, D.D. N. Enl. J. Med., 1995, 333, 450.
14. Alexander, L.; Aquino-DeJesus, M.J.; Chan, M.; Andiman, W.A. J. Virol., 2002, 76, 10533.
15. Safrin, S.; Grunfeild, C. AIDS, 1999, 13, 2493.
16. Pomerantz, R.; Horn, D.L. Nature Medicine, 2003, 9, 867.
17. Cvetkovic, R.S.; Goa, K.L. Drugs, 2003, 63, 769.
18. Kirby, J.M. Nat. Med., 1998, 4, 1302.
19. Dornadula, G. J. Infec. Dis., 2001, 183, 1682.
20. Kirby, J.M. Nat. Med., 1998, 4, 1302.
21. De Clercq, E. Mini Rev. Med. Chem., 2002, 2, 163.
22. Gilman, A. Am. J. Surg., 1963, 105, 574.
23. Papac, R. J. Biol. Med., 2001, 74, 391.
24. Li, M.C.; Hertz, R.; Bergenstal, D.M. N. Engl. J. Med., 1958, 259, 66.
25. Osborn, M.J.; Huennekens, F.M. J. Biol. Chem., 1958, 233, 969.
26. Skipper, H.E.; Thomson, J.R.; Elion, G.B.; Hitchings, G.H. Cancer Res, 1954, 14, 294.
27. Johnson, I.S.; Armstrong, J.G.; Goman, M.; Burnett, J.P. Jr. Cancer Res., 1963, 23, 1390.
28. Frei, E. Blood, 1965, 26, 642.
29. Saltz, L.B. N. Eng. J. Med., 2000, 343, 905.
30. Evans, B.D.; Raju, K.S.; Calvert, A.H.; Harland, S.J.; Wiltshaw, E. Cancer Treat. Rep., 1983, 67, 997.
31. Montgomery, J.A. Cancer Treat. Rep., 1976, 60, 651.
32. Walker, M.D.; Hurwitz, B.S. Cancer Chemother. Rep., 1970, 54, 263.
33. Witesel, L.; Mimmaugh, E.G.; De Costa, B.; Myers, C.E.; Neckers, LM. Proc. Natl. Acad. Sci. USA, 1994, 91, 8324.
34. Worland, P. J. Biochem. Pharmacol., 1993, 46, 1831.
35. Kris, M.G. JAMA, 2003, 290, 2149.
36. Cunningham, D. N. Eng. J. Med., 2004, 351, 337.
37. Adjei, A. A. J. Clin. Oncol., 2003, 21, 1760.
38. Hurwitz, H. N. Engl. J. Med., 2004, 351, 2335.
39. Gnarra, J.R. Nature Genet., 1994, 7, 85.
40. Chabner, B.A.; Roberts, Jr., T.G. Nature Reviews, 2005, 5, 65.
41. Folkman, J. N. Eng. J. Med., 1971, 285, 1182.
42. Jónsdóttir, S.O.; Jorgensen, F.S.; Brunak, S. Bioinformatics, 2005, 21, 2145.
43. Kitchen, D.B.; Decornez, H.; Furr, J.R.; Bajaorath, J. Nature Reviews, 2004, 5, 935.
44. Livingstone, D.J.; Manallack, D.T. QSAR Comb. Sci., 2003, 22, 510.
45. Erickson, J.A.; Jalate, M.; Robertson, D.H.; Lewis, R.A.; Vieth, M. J. Med. Chem., 2004, 47, 45.
46. Lombardino, J.G.; Lowe III, J.A. Nature Reviews, 2004, 3, 853.
47. Carr, R.A.E.; Congreve, M.; Murray, C.W.; Rees, D.C. Drug Discov. Today, 2005, 10, 987.
48. Roy, K. Mol. Divers., 2004, 8, 321.
49. Eisenstein, M.; Katzir, E.K.; C.R. Biologies, 2004, 327, 409.
50. Griffith, R.; Luu, T.T.T.; Garner, J.; Keler, P.A. J. Mol. Graph. Model., 2005, 23, 439.
51. Hemmateenejad, B.; Safarpour, M.A.; Miri, R.; Nesari, N. J. Chem. Inf. Model., 2005, 45, 190.
52. Bureeva, S.; Pravdivy, J.A.; Kaplun, A. Drug Discov. Today, 2005, 10, 1535.
53. Ruvinski, A.M.; Kovintsev, A.V. J. Comput Chem., 2005, 26, 1089.
54. Barbany, M.; Gutiérrez-de-Teran, H.; Sanz, F.; Villà-Freixa, J. PROTEINS: Structure, Function and Bioinformatics, 2004, 56, 585.
55. Huang, D.; Caflisch, A. J. Med. Chem., 2004, 47, 5791.
56. Jackson, M.; Sali, A. Ann. Rep. Med. Chem., 2004, 30, 259.
57. Votano, J.R.; Parham, M.; Hall, L.H.; Kier, L.B.; Oloff, S.; Tropsha, A.; Xie, Q.; Tong, W. Mutagenesis, 2004, 19, 365.
58. Cohen, M.S.; Zhang, C.; Shokat, K.M.; Taunton, J. Science, 2005, 308, 1318.
59. Oprea, T.I. (Ed.). In Chemoinformatics in Drug Discov., Wiley-VCH, Weinheim, 2005.
60. Van de Waterbeemd, H. (Ed.). In Drug Biovailability, Estimation of Permeability, Absorption and Bioavailability, Vol. 18, Methods and Principles in Medicinal Chemistry, Wiley-VCH, Weinheim, 2003.
61. van de Waterbeemd, H.; Gifford, E. Nat. Rev. Drug Discov., 2003, 2, 192.
62. Sulpizi, M.; Folkers, G.; Rothlisberger, U.; Carloni, P.; Scapozza, L. Quant. Struct.-Act. Relat., 2002, 21, 173.
63. Hemmateenejad, B.; Safarpour, M.A.; Miri, R.; Nesar, N. J. Chem. Inf. Model., 2005, 45, 190.
64. Raevsky, O.A.; Skvortsov, V.S. SAR QSAR Environ. Res., 2005, 16, 287.
65. Raha, K.; Merz, Jr. K. J. Med. Chem., 2005, 48, 4558.
66. Shoji, R. Curr. Comput.-Aided Drug Des., 2005, 2, 563.
67. Anderson, A.C. Chem. Biol., 2003, 10, 787.
68. Franco-Medina, J.L.; Golbraikh, A.; Oloff, Scott, O.; Castillo, R.; Tropsha, A. J. Comput.-Aided Mol. Des., 2005, 19, 229.
69. Smith, G.; Sternber, J.J.E. Curr. Opin. Struct. Biol., 2002, 12, 28.
70. Schneider, G.; Bohm, H.J. Combinat. Chem., 2002, 7, 64.
71. Swanson, J.M.J.; Henchman, R.H.; McCammon, J.A. Biophys. J., 2004, 86, 67.
72. Branson, K.M.; Smith, B.J. Aust. J. Chem., 2004, 57, 1029.
73. Sybyl User Guide, version 7.1, Tripos Inc., CA, USA, 2005.
74. Insight II User Guide, version 2005, Accelrys, CA, USA, 2005.
75. Schneider, G.; Fechner, U. Nature Reviews: Drug Discov., 2005, 4, 649.
76. Bajorach, J. Drug Discov. Today, 2004, 1, 14.
77. Enslein, K.; Gombar, U.K. Mutation Res., 1997, 379, 514.
78. Ewing, T.J.; Makino, S.; Sillman, A.G.T.; Kuntz, I.D.J. Comput.-Aided Mol. Des., 2001, 15, 411.
79. Verdonk, M.L.; Cole, J.C.; Hartshorn, M.J.; Murray, C.W.; Taylor, R.D. Proteins-Struct. Funct. Genet., 2003, 52, 609.
80. Todeschini, R.; Consonni, V. (Eds.). In Handbook of Molecular Descriptors, Wiley-VCH, Weinheim, 2000.
81. Devillers, J. and Balaban, A.T. (Eds.). In Topological Indices and Related Descriptors QSAR and QSPR, Gordon and Breach Science Publishers, The Netherlands, 1999.
82. Lipinski, C.A. Drug Discov. Today, 2004, 1, 337.
83. Kramer, B.; Rarey, M.; Lengauer, T. Proteins, 1999, 37, 228.
84. Morris, G.M. J. Comput. Chem., 1998, 19, 1639.
85. Weiner, S.J.; Kollman, P.A.; Mguyen, D.T.G.; Case, D.A. J. Comput. Chem., 1996, 7, 252.
86. Bohm, H.J. J. Comput. Aided Mol. Des., 1997, 11, 425.
87. Elkridge, M.D.; Murray, C.W.; Auton, C.R.; Pauloni, G.V.; Mee, R.P. J. Comp. Aided. Mol. Design, 1997, 11, 295.
88. Rarey, M.; Kramer, B.; Langauer, T.; Klebe, G. J. Mol. Biol., 1996, 261, 470.
89. Muegge, I. Perspectives Drug Disc. Des., 2000, 20, 19.
90. Gohke, H.; Hendlich, M.; Klebe, H. J. Mol. Biol., 2000, 295, 337.
91. Wang, R.; Lai, L.; Wang, S. J. Comp. Aided Mol. Design, 2002, 16, 11.
92. Jakupec, M.A.; Galanski, M.; Keppler, B.K. Rev. Physiol. Biochem. Pharmacol., 2003, 146, 1.
93. Silva, C.H.T.P.; Leopoldino, A.M.; Silva, E.H.T.; Espinoza, V.A.A., Taft, C. A. Int. J. Quant. Chem., 2005, 102, 1131.
94. Silva, C.H.T.P.; Carvalho, I.; Taft, C.A. J. Comput.-Aided Mol. Des., 2005, 19, 83.
95. Silva, C.H.T.P.; Del Ponte, G.; Neto, A.F.; Taft, C.A. Biorg. Chem., 2005, 33, 27.
96. Silva, C.H.T.P.; Taft, C.A. Biophys. Chem., 2005, 117, 73.
97. Xie, L.; Zhao, C.H.; Zhou, T.; Chen, H.F.; Fan, B.T.; Chen, X.H. Ma, J.Z.; Li, J.Y.; Bao, Z.Y.; Lo, Z.Y.D.; Lee, K.H. Bioorg. Med. Chem., 2005, 13, 6435.
98. Globish, C.; Pajeva, I.K.; Wiese, M. Bioorg. Med. Chem., 2006 2, 105.
99. Espinoza-Fonseca, L.M. Theor. Biol. Med. Model., 2005, 2, 38.
100. Turner, J.V.; Maddalena, D.J.; Agatonovic,-Kustrin, S. Pharm. Res., 2004, 21, 68.
101. Xu, W.; Li, Q. Curr. Med. Chem.- Anti-Cancer Agents, 2005, 5, 53.
102. Tremont-Lukats, J.W.; Gilbert, M.R. Cancer Control, 2003, 10, 125.
103. Kerr, J.S.; Slee, A.M.; Mousa, S.A. Expert Opin. Invest. Drugs, 2002, 11, 1765.
104. Rammath, N.; Creaven, P.J. Curr. Oncol. Rep., 2004, 6, 96.
105. Wang, J.L.; Xu, W.F. J. Chem. Res. Symp., 2003, 738.
106. Van Cutsem, E.; van der Velde, H.; Karasek, P.; Oettlle, H.; Vervenne, W.L.; Szawlowski, A.; Schoffski, P.; Post, S.; Verslype, C.; Neumann, H.; Safran, H.; Humlet, Y.; Perez, Ruixo, J.; Ma, Y.; van Hoff, D. J. Clin. Oncol., 2004, 22, 1430.
107. Miller, T.A.; Witter, D.J.; Belvedore, S. J. Med. Chem., 2003, 46, 5097.
108. Banerji, U.; Judson, I.; Workman, P. Curr. Cancer Drug Targets, 2003, 3, 385.
109. Bagmato, A.; Natali, P.G. J. Transl. Med., 2004, 2, 16.
110. Fenwick, S.W.; Toogood, G. J.; Lodge, J.P.A.; Hull, M.A. Gastroenterology, 2003, 125, 176.
111. De Clercq, E. Expert Opin. Emerg. Drugs, 2005, 10, 241.
112. De Clereq, E. Med. Res. Rev., 2002, 22, 531.
113. Aquaro, S.; Mennten, P.; Struyf, S.; Proost, P.; Van Damme, J.; De Clercq, E.; Schols, D. J. Virol., 2001, 75, 4402.
114. Moulard, M.; Lortat-Jacob, H.; Mondor, I.; Roca, G.; Wyatt, R.; Sodroski, J.; Zhao, L.; Olson, W.; Kwong, P.D.; Sattentau, Q.J. J. Virol., 2000, 74, 1948.
115. Kanamoto, T.; Kashiwada, Y.; Kanbara, K.; Gotoh, K.; Yoshimori, M.; Goto, T.; Sano, K.; Nakashima, H. Antimicrob. Agents Chemother., 2001, 45, 1225.
116. Tassignon, J.; Ismaili, J.; Le Moine, A.; Van Laethem, F.; Leo, O.; Vandevelde, M.; Goldman, M. Nat. Med., 1999, 5, 947.
117. Richman, D.D. AntiViral Ther., 2001, 6, 83.
118. Campiani, G.; Aiello, F.; Fabbrini, M.; Morelli, E.; Ramunno, A.; Armaroli, S.; Nacci, V.; Garofalo, A.; Greco, G.; Novellino, E.; Maga, G.; Spadari, S.; Bergamini, A.; Ventural, L.; Bongiovanni, B.; Capozzi, M.; Bolacchi, F.; Marini, S.; Coletta, M., Guiso, G.; Caccia, S. J. Med. Chem., 2001, 44, 305.
119. Hazuda, D.J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J.A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M.D. Science, 2000, 287, 646.
120. Ghezzi, S.; Noonan, D.M.; Aluigi, M.G.; Vallanti, G.; Cota, M.; Benelli, R.; Morini, M.; Reeves, J.D.; Vicenzi, E.; Poli, G.; Albini, A. Biochem. Biophys, Res. Commun., 2000, 270, 992.
121. Back, N.K.; van Wijk, A.; Remmerswaal, D.; van Monfort, M.; Nijhuis, M.; Schuurman, R.; Boucher, C.A. AIDS, 2000, 14, 101.
122. Rusconi, S.; La Seta Catamancio, S.; Citterio, P.; Kurtagic, S.; Violin, M.; Balotta, C.; Moroni, M.; Galli, M.; d'Arminio-Monforte, A. Agents Chemother., 2000, 44, 1328.
123. Hauber, I.; Bevec, D.; Heukeshoven, J.; Kratzer, F.; Horn, F.; Choidas, A., Harrer, T., Hauber J. J. Clin. Invest., 2005, 115, 6.
124. Vermeire, S.; Schols, D. J. Antimicrob Chemoth., 2005, 56, 270.
125. Nakata, H.; Maeda, K.; Miyakawa, T.; Shibayama, S.; Matsuo, M.; Takaoka, Y.; Ito, M.; Koyanagi, Y.; Mitsuya, H. J. Virol., 2005, 79, 2087.
126. Ryser, H.J.P.; Flückiger, R.A. Prog. Biophys. Mol. Biol., 2005, 88, 209.
127. Das, K.; Lewi, P.J.; Hugher, S.H.; Arnold, E.; Prog. Biophys. Mol. Biol., 2005, 88, 410.
128. Ohtaka, H. Freire, E. Prog. Biophys. Mol. Biol., 2005, 88, 193.
129. Sarafianos, S.G.; Hughes, S.H.; Arnold, E. Int. J. Biochem. Cell Biol., 2004, 36, 1706.
130. Lian, W.S.; Maddukuri, A.; Teslovich, T.M.; de la Fuente, C.; Agobttah, E.; Dadgar, S.; Kehn, K.; Hautaniemi, S.; Pumfery, A.; Stephan, D.A. Kashanchi, F. Retrovirology, 2005, 2, 20.
131. Sermely, P.; Agoston, V.; Pongor, S. Trends Pharmacol. Sci., 2005, 26, 178.